Unknown

Dataset Information

0

Screening of 5- and 6-Substituted Amiloride Libraries Identifies Dual-uPA/NHE1 Active and Single Target-Selective Inhibitors.


ABSTRACT: The K+-sparing diuretic amiloride shows off-target anti-cancer effects in multiple rodent models. These effects arise from the inhibition of two distinct cancer targets: the trypsin-like serine protease urokinase-type plasminogen activator (uPA), a cell-surface mediator of matrix degradation and tumor cell invasiveness, and the sodium-hydrogen exchanger isoform-1 (NHE1), a central regulator of transmembrane pH that supports carcinogenic progression. In this study, we co-screened our library of 5- and 6-substituted amilorides against these two targets, aiming to identify single-target selective and dual-targeting inhibitors for use as complementary pharmacological probes. Closely related analogs substituted at the 6-position with pyrimidines were identified as dual-targeting (pyrimidine 24 uPA IC50 = 175 nM, NHE1 IC50 = 266 nM, uPA selectivity ratio = 1.5) and uPA-selective (methoxypyrimidine 26 uPA IC50 = 86 nM, NHE1 IC50 = 12,290 nM, uPA selectivity ratio = 143) inhibitors, while high NHE1 potency and selectivity was seen with 5-morpholino (29 NHE1 IC50 = 129 nM, uPA IC50 = 10,949 nM; NHE1 selectivity ratio = 85) and 5-(1,4-oxazepine) (30 NHE1 IC50 = 85 nM, uPA IC50 = 5715 nM; NHE1 selectivity ratio = 67) analogs. Together, these amilorides comprise a new toolkit of chemotype-matched, non-cytotoxic probes for dissecting the pharmacological effects of selective uPA and NHE1 inhibition versus dual-uPA/NHE1 inhibition.

SUBMITTER: Buckley BJ 

PROVIDER: S-EPMC8000185 | biostudies-literature | 2021 Mar

REPOSITORIES: biostudies-literature

altmetric image

Publications

Screening of 5- and 6-Substituted Amiloride Libraries Identifies Dual-uPA/NHE1 Active and Single Target-Selective Inhibitors.

Buckley Benjamin J BJ   Kumar Ashna A   Aboelela Ashraf A   Bujaroski Richard S RS   Li Xiuju X   Majed Hiwa H   Fliegel Larry L   Ranson Marie M   Kelso Michael J MJ  

International journal of molecular sciences 20210315 6


The K<sup>+</sup>-sparing diuretic amiloride shows off-target anti-cancer effects in multiple rodent models. These effects arise from the inhibition of two distinct cancer targets: the trypsin-like serine protease urokinase-type plasminogen activator (uPA), a cell-surface mediator of matrix degradation and tumor cell invasiveness, and the sodium-hydrogen exchanger isoform-1 (NHE1), a central regulator of transmembrane <i>p</i>H that supports carcinogenic progression. In this study, we co-screene  ...[more]

Similar Datasets

| S-EPMC10009331 | biostudies-literature
| S-EPMC5206513 | biostudies-literature
| S-EPMC6290913 | biostudies-literature
| S-EPMC9496321 | biostudies-literature
| S-EPMC6158287 | biostudies-literature
| S-EPMC11869419 | biostudies-literature
| S-EPMC4007837 | biostudies-literature
| S-EPMC10949195 | biostudies-literature
| S-EPMC10855164 | biostudies-literature
| S-EPMC7362394 | biostudies-literature